Inactive Instrument

Cephalon, Inc. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	AstraZeneca : Teva reach deal with states in Medicaid pricing case	RE
2014	Actavis : Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock	RE

AstraZeneca : Teva reach deal with states in Medicaid pricing case	15-11-04	RE
Actavis : Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock	14-12-09	RE

CEPHALON : Teva Completes Acquisition of Cephalon	11-10-14	BU
CEPHALON : Announces Enrollment In the Risk Evaluation and Mitigation Strategy Program for FENTORA and ACTIQ	11-10-13	PU
CEPHALON : Teva and Cephalon Receive European Commission Approval For Acquisition	11-10-13	BU
CEPHALON : Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015	11-08-22	PR
CEPHALON : Reported Financial Results for the Second Quarter of 2011	11-08-02	PR

CEPHALON : bond des bénéfices au premier trimestre	11-05-04
CEPHALON : Valeant Pharmaceuticals lance une OPA de 5,7 MdUSD sur CEPHALON	11-03-30

Sector

	1st Jan change	Capi.
UPM-KYMMENE OYJ	-6.02%	18.19B
SUZANO S.A.	+8.07%	15.04B
SVENSKA CELLULOSA AKTIEBOLAGET SCA	+2.35%	10.06B
HOLMEN AB	-1.86%	6.14B
EMPRESAS CMPC S.A.	+14.80%	5B
OJI HOLDINGS CORPORATION	+17.94%	4.06B
THE NAVIGATOR COMPANY	+16.63%	3.14B
CENTURY TEXTILES AND INDUSTRIES LIMITED	+52.69%	2.57B
XIANHE CO.,LTD.	+9.98%	1.73B